Doctor profile · Federal record
Dr. Khaled El-Shami, MD
Medical Oncology Physician (CMS: Hematology/Oncology) · Washington, DC
- NPI 1639225204
- MIPS 75.0 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2150 Pennsylvania Ave Nw
Washington, DC 200373201
(202) 741-2478
fax (202) 741-2487 - Mailing address
-
5255 Loughboro RD Nw
Washington, DC 200162633
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- August 20, 2021
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Maryland #D65486
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639225204. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
891
Distinct HCPCS
5
Medicare allowed
$129,721
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 427 | 164 | $159 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 225 | 44 | $131 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 163 | 115 | $107 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 54 | 46 | $190 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 22 | 22 | $202 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 100. This provider delivers 8.9× the peer median.Open Payments
Industry payments received
All-time total
$147
Transactions
4
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 1 | $74.99 | |
| Celgene Corporation | 1 | $26.69 | |
| AstraZeneca Pharmaceuticals LP | 1 | $24.48 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $20.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
218
Patients
38
Total drug cost
$1,148,142
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 37 | 12 | $786 |
| Acyclovir | Generic | 32 | 14 | $949 |
| Revlimid (Lenalidomide) | Brand | 26 | 0 | $614,542 |
| Hydroxyurea | Generic | 25 | 0 | $998 |
| Calquence (Acalabrutinib Maleate) | Brand | 20 | 0 | $319,072 |
| Prochlorperazine Maleate | Generic | 15 | 12 | $159 |
| Venclexta (Venetoclax) | Brand | 15 | 0 | $201,384 |
| Danazol | Generic | 14 | 0 | $9,925 |
| Prednisone | Generic | 12 | 0 | $70 |
| Allopurinol | Generic | 11 | 0 | $104 |
Frequently asked questions
What is Dr. Khaled El-Shami's medical specialty?
Dr. Khaled El-Shami practices Medical Oncology Physician in Washington, DC.
Where does Dr. Khaled El-Shami practice?
Dr. Khaled El-Shami practices at 2150 Pennsylvania Ave Nw, Washington, DC 200373201. Office phone: 2027412478.
What is Dr. Khaled El-Shami's NPI?
Dr. Khaled El-Shami's National Provider Identifier (NPI) is 1639225204, issued by NPPES.
Does Dr. Khaled El-Shami accept Medicare assignment?
Dr. Khaled El-Shami does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Khaled El-Shami commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.